Amherstburg, CA, United States of America

Adam Faccenda

This inventor holds 1 USPTO granted patent. Top assignee: University of Windsor. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam Faccenda. Retrieved from https://idiyas.com/inventor/adam-faccenda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Adam Faccenda

Introduction

Adam Faccenda is a notable inventor based in Amherstburg, Canada. He has made significant strides in the field of medical technology, particularly in the development of therapeutic delivery systems. His work focuses on improving patient care through innovative solutions.

Latest Patents

Faccenda holds a patent for an "Apparatus for the controlled release of topical nitric oxide." This invention features a stable delivery system designed for the therapeutic release and application of nitric oxide to patients suffering from cutaneous injuries or wounds. The system incorporates S-nitrosothiol and transition element nanoparticles, which react to release and diffuse nitric oxide into the affected area. He has 1 patent to his name.

Career Highlights

Faccenda is affiliated with the University of Windsor, where he contributes to research and development in medical technologies. His work is pivotal in advancing therapeutic methods that enhance healing processes for patients.

Collaborations

Faccenda collaborates with esteemed colleagues, including Bulent Mutus and Arthur Jarosz. Their combined expertise fosters a productive research environment that drives innovation in their field.

Conclusion

Adam Faccenda's contributions to medical technology exemplify the impact of innovative thinking in healthcare. His patent for the controlled release of nitric oxide showcases his commitment to improving patient outcomes through advanced therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…